2025 annual financial data

Acumen Pharmaceuticals 2025 Net margin

Direct answer

Net margin was Not calculable.

Operating income was -123,832,000 USD and net income was -121,335,000 USD.
Operating cash flow was -115,538,000 USD.

Get free Acumen Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-123,832,000 USD
Net income
-121,335,000 USD
Operating cash flow
-115,538,000 USD